| Recruiting | Scout Dose of Resin Microspheres NCT07476651 | Seoul National University Hospital | N/A |
| Not Yet Recruiting | NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer NCT07314385 | National Taiwan University Hospital | Phase 1 |
| Not Yet Recruiting | A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread NCT07256223 | Fudan University | Phase 2 |
| Not Yet Recruiting | Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignan NCT07118566 | China Medical University, China | Phase 2 |
| Recruiting | Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors NCT07001592 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Phase 1 |
| Recruiting | LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis NCT06848465 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 1 |
| Not Yet Recruiting | The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer NCT06609434 | Peking University Cancer Hospital & Institute | N/A |
| Recruiting | Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver NCT06356584 | Shandong Cancer Hospital and Institute | Phase 2 |
| Enrolling By Invitation | Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Bi NCT06671418 | Erasmus Medical Center | Phase 3 |
| Not Yet Recruiting | A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis NCT05359393 | Fudan University | Phase 2 |
| Unknown | Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis NCT05524155 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases NCT06980792 | Azienda Ospedaliero-Universitaria di Modena | — |
| Recruiting | Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from NCT05098847 | Fudan University | Phase 2 |
| Completed | The Role of Intraoperative Hepatic Ultrasonography in Gastrointestinal or Pancreatic Neuroendocrine Tumor NCT06779708 | Istituto Clinico Humanitas | — |
| Withdrawn | A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metas NCT04420130 | Yanqiao Zhang | N/A |
| Unknown | To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ult NCT04417010 | Peking University Cancer Hospital & Institute | — |
| Completed | Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Prod NCT03801915 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Advanced Therapies for Liver Metastases NCT04622423 | IRCCS San Raffaele | — |
| Terminated | Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma NCT03785210 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | EPA for Metastasis Trial 2 NCT03428477 | Mark A Hull, PhD FRCP | Phase 3 |
| Withdrawn | Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI NCT02651090 | Northeastern Ohio Radiology Research and Education Fund | Phase 3 |
| Terminated | Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy NCT02728167 | Centre Leon Berard | N/A |
| Active Not Recruiting | Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy NCT02597348 | Assistance Publique - Hôpitaux de Paris | N/A |
| Terminated | Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver M NCT02453490 | Zhejiang University | Phase 3 |
| Unknown | Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treat NCT02632201 | Second Military Medical University | Phase 1 / Phase 2 |
| Completed | A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program NCT02218801 | European Organisation for Research and Treatment of Cancer - EORTC | — |
| Completed | Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC) NCT02316028 | Universitair Ziekenhuis Brussel | Phase 1 / Phase 2 |
| Unknown | Pringle Manoeuvre Versus Portal Vein Clamping for Liver Resection NCT02042794 | The Leeds Teaching Hospitals NHS Trust | — |
| Completed | Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection f NCT01834014 | EPS Corporation | N/A |
| Terminated | Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer NCT01856322 | National Cancer Institute (NCI) | Phase 2 |
| Completed | The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver NCT01785212 | Medical University of Vienna | N/A |
| Unknown | Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis NCT01962376 | Hebei Medical University | Phase 4 |
| Unknown | Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver NCT02380131 | Hebei Medical University | Phase 4 |
| Withdrawn | Response of Hepatic Tumors to Radioembolization NCT01775280 | University of Zurich | Phase 2 |
| Unknown | Optimization of Health Expenditure in Liver Surgery NCT01715402 | Centre Hospitalier Universitaire, Amiens | — |
| Unknown | Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchron NCT01923987 | Korea Cancer Center Hospital | Phase 2 |
| Completed | Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets NCT01632722 | Yonsei University | Phase 2 |
| Recruiting | Liver Transplantation and Colorectal Cancer NCT01479608 | Oslo University Hospital | N/A |
| Terminated | Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study) NCT01266187 | RWTH Aachen University | N/A |
| Unknown | Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor NCT01511146 | Copenhagen University Hospital at Herlev | Phase 2 |
| Unknown | Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultr NCT01347424 | Sun Yat-sen University | Phase 2 |
| Terminated | Total Preoperative MR Diagnostic Evaluation Versus Standard Diagnostic Evaluation in Patients With Rectal Canc NCT01544452 | Herlev Hospital | N/A |
| Completed | National Registry of Hepatic Metastases From Non-Colorectal Cancer" NCT07180641 | Clinica Universidad de Navarra, Universidad de Navarra | — |
| Completed | Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery. NCT00874224 | Maastricht University Medical Center | N/A |
| Completed | Radioactive Holmium Microspheres for the Treatment of Liver Metastases NCT01031784 | UMC Utrecht | Phase 1 |
| Unknown | Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal NCT01035385 | Guangdong Provincial People's Hospital | Phase 3 |
| Completed | Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver NCT00833807 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Sorafenib-RT Treatment for Liver Metastasis (SLIM) NCT00892424 | University Health Network, Toronto | Phase 1 / Phase 2 |
| Unknown | Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal C NCT00594529 | Kyoto University | Phase 2 |
| Unknown | Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 a NCT00868569 | Fudan University | Phase 4 |
| Completed | Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3) NCT00914615 | University Health Network, Toronto | Phase 2 |
| Withdrawn | Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin NCT00430313 | M.D. Anderson Cancer Center | N/A |
| Completed | Evaluation of Preoperative Investigations in Patients With Liver Cancer NCT00408122 | Odense University Hospital | — |
| Completed | Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases NCT00083785 | Light Sciences LLC | Phase 2 |
| Completed | Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metas NCT00068068 | Light Sciences LLC | Phase 2 |
| Completed | Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors NCT00028405 | Light Sciences LLC | Phase 1 |